I think this aspect is more discretionary. For example, there's funding of $1.8 billion to buy more COVID-19 rapid tests. The government could have decided to buy less or buy none at all, and leave that to other jurisdictions.
There's also funding for Global Affairs to support public health measures in developing countries, which is, I think, discretionary. Similarly, there's funding for the Public Health Agency of Canada to provide $700 million to fund medical research and vaccine development, which is discretionary. Whether it would be a good decision to abandon that or not, I leave others to determine. There are other funding decisions that are discretionary, and they're under the COVID-19 funding rubric.